210 related articles for article (PubMed ID: 18201229)
1. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity.
Diwan AH; Skelton HG; Horenstein MG; Kelly DR; Barrett TL; Bussian AH; Sanders DY; Lazar AJ; Prieto VG; Smith KJ
J Cutan Pathol; 2008 Jul; 35(7):647-50. PubMed ID: 18201229
[TBL] [Abstract][Full Text] [Related]
2. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans association with nuchal-type fibroma.
Diwan AH; Horenstein MG
J Cutan Pathol; 2004 Jan; 31(1):62-6. PubMed ID: 14675287
[TBL] [Abstract][Full Text] [Related]
4. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.
Jha P; Moosavi C; Fanburg-Smith JC
Ann Diagn Pathol; 2007 Apr; 11(2):81-8. PubMed ID: 17349565
[TBL] [Abstract][Full Text] [Related]
5. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
6. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
[TBL] [Abstract][Full Text] [Related]
7. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report.
Warbrick-Smith J; Hollowood K; Birch J
J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):e785-7. PubMed ID: 20655288
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
10. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
11. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
[TBL] [Abstract][Full Text] [Related]
12. FNA diagnosis of giant cell fibroblastoma: a case report of an unusual pediatric soft tissue tumor.
Davis JL; Mathes E; Berry AB
Diagn Cytopathol; 2015 Apr; 43(4):325-8. PubMed ID: 25088682
[TBL] [Abstract][Full Text] [Related]
13. Composite dermatofibrosarcoma protuberans-giant cell fibroblastoma recurring as Bednár tumor-giant cell fibroblastoma with mucoid lakes and with amputation neuroma.
Zámecník M; Michal M; Chlumská A
Cesk Patol; 2002 Oct; 38(4):173-7. PubMed ID: 12629865
[TBL] [Abstract][Full Text] [Related]
14. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
Harvell JD; Kilpatrick SE; White WL
Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
[TBL] [Abstract][Full Text] [Related]
15. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1994 Aug; 21(4):324-9. PubMed ID: 7528229
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
[TBL] [Abstract][Full Text] [Related]
17. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
[TBL] [Abstract][Full Text] [Related]
18. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.
Elgart GW; Hanly A; Busso M; Spencer JM
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):315-7. PubMed ID: 10025857
[TBL] [Abstract][Full Text] [Related]
19. [Myxoid dermatofibrosarcoma protuberans: a clinicopathologic analysis of 16 cases].
Ren WM; Sheng WQ; Wang J
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):456-60. PubMed ID: 22932456
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma Protuberans: An Immunomarker Study of 57 Cases That Included Putative Mesenchymal Stem Cell Markers.
Song JS; Kim EJ; Park CS; Cho KJ
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):586-591. PubMed ID: 28362700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
